Generali Investments Towarzystwo Funduszy Inwestycyjnych Moderna, Inc. Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $172 Billion
- Q4 2024
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Moderna, Inc. stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 400 shares of MRNA stock, worth $13,668. This represents 0.01% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$13,668
Previous $26.7 Million
37.78%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
912Shares Held
235MCall Options Held
10.6MPut Options Held
18.7M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.37 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.33 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$873 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$576 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$247 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...